Effect on glucose homeostasis in diabetes model (unknown origin) assessed as release of GIP at 30 mg/kg, po administered intratracheally measured 120 mins post glucose challenge
Effect on glucose homeostasis in diabetes model (unknown origin) assessed as release of GIP at 30 mg/kg, po administered intratracheally measured 60 mins post glucose challenge
Effect on glucose homeostasis in diabetes model (unknown origin) assessed as release of GIP at 30 mg/kg, po administered intratracheally measured 40 mins post glucose challenge
Effect on glucose homeostasis in diabetes model (unknown origin) assessed as release of GIP at 30 mg/kg, po administered intratracheally measured 20 mins post glucose challenge
Effect on glucose homeostasis in diabetes model (unknown origin) assessed as release of GIP at 30 mg/kg, po administered intratracheally measured 30 mins before glucose challenge
Effect on glucose homeostasis in diabetes model (unknown origin) assessed as release of GIP at 3 mg/kg, po administered intratracheally measured 120 mins post glucose challenge
Effect on glucose homeostasis in diabetes model (unknown origin) assessed as release of GIP at 3 mg/kg, po administered intratracheally measured 60 mins post glucose challenge
Effect on glucose homeostasis in diabetes model (unknown origin) assessed as release of GIP at 3 mg/kg, po administered intratracheally measured 40 mins post glucose challenge
Effect on glucose homeostasis in diabetes model (unknown origin) assessed as release of GIP at 3 mg/kg, po administered intratracheally measured 20 mins post glucose challenge
Effect on glucose homeostasis in diabetes model (unknown origin) assessed as release of GIP at 3 mg/kg, po administered intratracheally measured 30 mins before glucose challenge